Skip to main content
      RT @ejdein1: #EULAR2021 OP0133 retinal toxicity with HCQ use. ⬆️ risk:
      ⭐️Duration 10-14.9 yr (OR 5)
      ⭐️Durat

      Eric Dein ejdein1

      4 years 5 months ago
      #EULAR2021 OP0133 retinal toxicity with HCQ use. ⬆️ risk: ⭐️Duration 10-14.9 yr (OR 5) ⭐️Duration >15 yr (OR 19) ⭐️Dose >7 mg/kg/d (OR 4.6) ⭐️Cum dose >2000 g Atherosclerosis, age >80 seen in multi-var analysis But didn't have HCQ levels to predict risk @MaxKonigMD @RheumNow https://t.co/DzWWm0U64L
      RT @doctorRBC: TNFi use associated with ⬇️ radiographic sacroilitis progression in patients with AxSpA
      ⭐️effect

      Robert B Chao, MD doctorRBC

      4 years 5 months ago
      TNFi use associated with ⬇️ radiographic sacroilitis progression in patients with AxSpA ⭐️effect becomes evident between 2 and 4 years after treatment Abs#OP0137 #EULAR2021 @RheumNow
      RT @doctorRBC: Machine learning to model risk for SSc-ILD
      ⭐️predict time to lung function decline
      ⭐️needs larg

      Robert B Chao, MD doctorRBC

      4 years 5 months ago
      Machine learning to model risk for SSc-ILD ⭐️predict time to lung function decline ⭐️needs larger sample size Abs#OP0150 #EULAR2021 @RheumNow
      RT @ARD_BMJ: OP0186 #EULAR2021 by Dr. Mariele Gatto.

      Anti-cancer effect of immunotherapy with ICI is believed to be me

      ARD & RMD Open ARD_BMJ

      4 years 5 months ago
      OP0186 #EULAR2021 by Dr. Mariele Gatto. Anti-cancer effect of immunotherapy with ICI is believed to be mediated by CD8 positive Tc cells. It is not known if other cells get activated. This study looks at B cells. Transitional B cells ⬆️ in ICI induced arthritis (CP-IA). /TK https://t.co/szFF81SKVL
      RT @synovialjoints: No requirement to stop cDMARDs before surgery. For biologics stop 1 dose before and restart 14 days

      Dr. Antoni Chan synovialjoints

      4 years 5 months ago
      No requirement to stop cDMARDs before surgery. For biologics stop 1 dose before and restart 14 days post op, JAKi stop 7 days before, restart 14 days post op, glucocorticoids >10mg/day increases risk of infection in #rheumatoidarthritis Michael D George #EULAR2021
      RT @Stiddyo: #POS0093 Collaborative registry studies are to be encouraged! BUT
      @k_lauper outlines the heterogenity betwe

      Paul Studenic Stiddyo

      4 years 5 months ago
      #POS0093 Collaborative registry studies are to be encouraged! BUT @k_lauper outlines the heterogenity between registries concerning #AE reporting - Jak-pot study - 18 registries with #RA patients on #tofacitinib - Rates of discontinuation vary across registry #EULAR2021 @RheumNow https://t.co/oczJAG8hzv
      RT @MeralElRamahiMD: SPACING trial OP0138 at #EULAR2021
      ⭐️RCT by the French showing non-inferiority of spacing TNFi

      Meral K. El Ramahi, MD MeralElRamahiMD

      4 years 5 months ago
      SPACING trial OP0138 at #EULAR2021 ⭐️RCT by the French showing non-inferiority of spacing TNFi in r-axSpA pts w/ LDA (BASDAI<4 x 6mo) ⭐️ 88% in spacing group remained w/ LDA vs 91.5% in standard tx ⭐️ADA, CTZ, GOL, IFX spaced by 1w intervals. ETN by 3-4d & 1w. @RheumNow
      RT @EMEUNET: Immune events with #checkpointinhibitors 🧐which are the most common? Interesting talk by Maria Suarez-Al

      EMEUNET EMEUNET

      4 years 5 months ago
      Immune events with #checkpointinhibitors 🧐which are the most common? Interesting talk by Maria Suarez-Almazor at #EULAR2021 @eular_org https://t.co/PFPPL4cqOG
      RT @Janetbirdope: You put a pt on a #Jaki What is most likely infection that will occur? #EULAR2021 @RheumNow @eular_org

      Janet Pope Janetbirdope

      4 years 5 months ago
      You put a pt on a #Jaki What is most likely infection that will occur? #EULAR2021 @RheumNow @eular_org
      RT @drdavidliew: So how do irAEs work?

      Dr. Anne Bass @lovetolearn27 @HSpecialSurgery gives #EULAR2021 a possible concep

      David Liew drdavidliew

      4 years 5 months ago
      So how do irAEs work? Dr. Anne Bass @lovetolearn27 @HSpecialSurgery gives #EULAR2021 a possible conceptual framework @LCalabreseDO @CCalabreseDO @cappelliMD @got_rheum @MarieKostine and so many other good people! @RheumNow https://t.co/5eOZDwkGO6
      RT @AurelieRheumo: An original way of differentiating RA from PsA!
      The shape of the second MCP in HR-pQCT is enough to

      Aurelie Najm AurelieRheumo

      4 years 5 months ago
      An original way of differentiating RA from PsA! The shape of the second MCP in HR-pQCT is enough to train a neural network with high accuracy for recognition of -HC 94% -RA 84% -PsA 89% and an AUC of 91%. #EULAR2021 @RheumNow #OP0145 https://t.co/BrwFQpX310
      RT @ejdein1: Presentation 3480 at #EULAR2021. Your patient is on CellCept, has negative COVID spike IgG and IgM antibodi

      Eric Dein ejdein1

      4 years 5 months ago
      Presentation 3480 at #EULAR2021. Your patient is on CellCept, has negative COVID spike IgG and IgM antibodies after vaccination with mRNA vaccination x2. What do you counsel on this test? @RheumNow
      RT @KDAO2011: Anifrolumab pooled TULIP-1&amp;-2 data on rash and arthritis in SLE more effective in pts with high IFN si

      k dao KDAO2011

      4 years 5 months ago
      Anifrolumab pooled TULIP-1&-2 data on rash and arthritis in SLE more effective in pts with high IFN signals (pts with low IFN may benefit, but they had less rash but more arthritis)- Dr. J Merrill #OP0131 #EULAR2021 @rheumnow
      RT @KDAO2011: ⬆️prevalence of HCQ retinopathy: Kaiser Permanente 676 pts retrospect study #OP0133
      👉6.8% (n=46) ha

      k dao KDAO2011

      4 years 5 months ago
      ⬆️prevalence of HCQ retinopathy: Kaiser Permanente 676 pts retrospect study #OP0133 👉6.8% (n=46) had HCQ retinopathy w/ risks: 👉age>80 (OR 3.83) 👉h/o atherosclerosis (OR 2.99), 👉cum. dose >2000 mg (OR 15.8) 👉10-15 yrs use (OR 4.44) 👉>15 yrs (OR 19) #EULAR2021 @rheumnow https://t.co/QA8HHXdnjL
      ×